dpp4 and glp-1 receptor agonist versus DPP-4 inhibitor kidney and cardiovascular outcomes in clinical practice in type-2 diabetes The mechanism of action of

This insulin boost helps lower blood sugar levels after meals, promoting better glucose control and metabolic balance

The post suggests smaller, more frequent meals, avoiding high-fat and heavily processed foods that ferment, staying well hydrated, and increasing soluble fiber gradually to support gut bacteria

If you want a drug you can start this month under a doctor's supervision, Zepbound is the only one of the two that qualifies

Abbreviations CI: Confidence interval CNS: Central nervous system CPT: Current Procedural Terminology GI: Gastrointestinal GLP-1RA: Glucagon-like peptide-1 receptor agonist HCO: Healthcare organization HIPAA: Health Insurance Portability and Accountability Act HR: Hazard ratio ICD-10-CM: International Classification of Diseases, Tenth Revision, Clinical Modification LOINC: Logical Observation Identifiers Names and Codes REM: Rapid eye movement RLS: Restless legs syndrome RR: Risk ratio STROBE: Strengthening the Reporting of Observational Studies in Epidemiology T2DM: Type 2 diabetes mellitus TNX: TriNetX curated code References Michos ED, Lopez-Jimenez F, Gulati M

Zepbound activates GLP-1 and GIP receptors simultaneously-reducing appetite significantly within days, slowing gastric emptying by approximately 40%, and producing average weight loss of up to 21% by week 72

Safety advice liver Lacarnit 330 Tablet is considered safe for use in patients with liver disease